Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity.
De Matteis S, Dicataldo M, Casadei B, Storci G, Laprovitera N, Arpinati M, Maffini E, Cortelli P, Guarino M, Vaglio F, Naddeo M, Sinigaglia B, Zazzeroni L, Guadagnuolo S, Tomassini E, Bertuccio SN, Messelodi D, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: bertuccio sn. Front Immunol. 2023 Jan 16;13:1058126. doi: 10.3389/fimmu.2022.1058126. eCollection 2022. Front Immunol. 2023. PMID: 36726971 Free PMC article.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
De Matteis S, Casadei B, Lolli G, Dicataldo M, Barbato F, Dan E, Paccagnella A, Sinigaglia B, Bertuzzi C, Arcari A, Zazzeroni L, Bernuzzi P, Laprovitera N, Storci G, Bertuccio SN, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: bertuccio sn. Front Immunol. 2022 Oct 6;13:994731. doi: 10.3389/fimmu.2022.994731. eCollection 2022. Front Immunol. 2022. PMID: 36275688 Free PMC article.
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Gottardi F, Baccelli F, Leardini D, Di Battista A, Castellucci P, D'Amico D, Serravalle S, Bertuccio SN, Messelodi D, Prete A, Masetti R. Gottardi F, et al. Among authors: bertuccio sn. Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37350036 No abstract available.
Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation.
Messelodi D, Strocchi S, Bertuccio SN, Baden P, Indio V, Giorgi FM, Taddia A, Serravalle S, Valente S, di Fonzo A, Frattini E, Bernardoni R, Pession A, Grifoni D, Deleidi M, Astolfi A, Pession A. Messelodi D, et al. Among authors: bertuccio sn. Commun Biol. 2023 Apr 19;6(1):431. doi: 10.1038/s42003-023-04813-2. Commun Biol. 2023. PMID: 37076591 Free PMC article.
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).
Fiore M, Taddia A, Indio V, Bertuccio SN, Messelodi D, Serravalle S, Bandini J, Spreafico F, Perotti D, Collini P, Di Cataldo A, Pasquinelli G, Chiarini F, Fois M, Melchionda F, Pession A, Astolfi A. Fiore M, et al. Among authors: bertuccio sn. Int J Mol Sci. 2023 Feb 13;24(4):3743. doi: 10.3390/ijms24043743. Int J Mol Sci. 2023. PMID: 36835166 Free PMC article.
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
Baccelli F, Leardini D, Muratore E, Messelodi D, Bertuccio SN, Chiriaco M, Cancrini C, Conti F, Castagnetti F, Pedace L, Pession A, Yoshimi A, Niemeyer C, Tartaglia M, Locatelli F, Masetti R. Baccelli F, et al. Among authors: bertuccio sn. Hum Genomics. 2022 Sep 19;16(1):40. doi: 10.1186/s40246-022-00414-y. Hum Genomics. 2022. PMID: 36123612 Free PMC article.
Role of CBL Mutations in Cancer and Non-Malignant Phenotype.
Leardini D, Messelodi D, Muratore E, Baccelli F, Bertuccio SN, Anselmi L, Pession A, Masetti R. Leardini D, et al. Among authors: bertuccio sn. Cancers (Basel). 2022 Feb 8;14(3):839. doi: 10.3390/cancers14030839. Cancers (Basel). 2022. PMID: 35159106 Free PMC article. Review.
29 results